豪能股份 20260107 摘要 豪能股份通过参股公司合作，积极推进商业航天业务，专注于高附加值 阀门管路产品，如电磁阀和低温阀，并已建立相应的产能和产线。 公司为火箭提供发动机和舰体所需的阀门，单枚火箭舰体阀门价值约 100-200 万元，发动机阀门价值约 50 万元，大型火箭总价值可达 600- 700 万元，回收型火箭市场空间更大。 豪能股份与南箭等多家商业火箭公司合作，并为上海红勤、北京星火时 空等公司提供卫星阀门产品，积极拓展商业航天市场。 公司正在建设航空航天总部基地，预计年底完工，整合所有航空航天业 务，进一步扩大在商业航天领域的布局。 公司计划投资火箭结构件制造，包括尾段、中段壳段和整流罩等，并逐 步扩展到液体火箭贮箱等核心部件的制造。 豪能股份优先开发技术难度高、价值量大的阀门管路产品，已进入商业 航天客户供应体系，未来将延伸至相对简单的结构件制造。 公司阀门技术团队实力雄厚，具备全面生产制造装配及实验验证能力， 使其能够快速切入火箭和卫星阀门细分赛道，预计未来三年基本面持续 向好。 Q&A 豪能股份在商业航天领域的布局和发展情况如何？ 豪能股份自 2021 年开始布局商业航天领域，首先通过 ...

Investment Rating - The investment rating for the company is "Accumulate" with a target price of 30.99 CNY, compared to the current price of 26.84 CNY [6]. Core Insights - The company has demonstrated steady performance growth, with significant improvements in gross margin and cash flow metrics. It is also accelerating its overseas expansion and actively exploring new production capabilities in controllable nuclear fusion [2][3]. Financial Summary - Total revenue for 2023 is projected at 13,309 million CNY, with a growth rate of 4.0%. By 2025, revenue is expected to reach 16,040 million CNY, reflecting a 16.9% increase [4]. - Net profit attributable to shareholders for 2023 is estimated at 1,216 million CNY, with a slight increase of 0.5%. The forecast for 2025 is 1,046 million CNY, indicating a 13.4% growth [4]. - Earnings per share (EPS) is projected to be 1.24 CNY for 2023, decreasing to 1.07 CNY in 2024, and then increasing to 1.38 CNY by 2027 [4]. - The return on equity (ROE) is expected to be 13.7% in 2023, declining to 10.0% in 2024, and gradually improving to 10.9% by 2027 [4]. Performance Metrics - For the first three quarters of 2025, the company achieved a revenue of 11,428 million CNY, a year-on-year increase of 10.39%, and a net profit of 757 million CNY, up 12.14% [13]. - The gross margin for the first three quarters of 2025 was 20.64%, with a net margin of 7.44%, both showing year-on-year improvements [13]. - Cash flow from operating activities significantly improved, with a net cash flow of 19,470 million CNY for the first three quarters of 2025, marking a 140.03% increase year-on-year [13]. Strategic Initiatives - The company is actively expanding its overseas market presence, planning to establish subsidiaries in Singapore and Malaysia to enhance its global market responsiveness and customer development [13]. - It is also focusing on developing new production capabilities in strategic emerging industries, particularly in controllable nuclear fusion, which includes providing high-quality low-temperature equipment and high-purity specialty gases [13].

Core Insights - The company demonstrated robust performance in Q3 2025, with significant improvements in gross margin and cash flow, while accelerating its overseas expansion and exploring new production fields such as controllable nuclear fusion [1][3][4]. Financial Performance - In Q1-Q3 2025, the company achieved revenue of 11.428 billion yuan, a year-on-year increase of 10.39%, and a net profit attributable to shareholders of 757 million yuan, up 12.14%. In Q3 2025, revenue reached 4.101 billion yuan, growing 13.12% year-on-year, with a net profit of 278 million yuan, reflecting a 16.79% increase [3]. - The company's gross margin and net margin for Q1-Q3 2025 were 20.64% and 7.44%, respectively, showing year-on-year improvements of 0.24 percentage points and 0.32 percentage points. For Q3 2025, the gross margin was 20.49% and the net margin was 7.70%, with year-on-year increases of 0.63 percentage points and 0.48 percentage points, and quarter-on-quarter increases of 0.44 percentage points and 0.12 percentage points [3]. - The company effectively managed its expense ratio, with a comprehensive expense ratio of 10.16% for Q1-Q3 2025 and 10.30% for Q3 2025, down 0.99 percentage points and 0.30 percentage points year-on-year, respectively. Operating cash flow significantly improved, with a net cash flow from operating activities of 1.947 billion yuan for Q1-Q3 2025, up 140.03%, and 732 million yuan for Q3 2025, up 271.44% year-on-year [3]. Strategic Initiatives - The company is accelerating its overseas strategy by planning to establish subsidiaries in Singapore and Malaysia, aiming to enhance its market information acquisition and response efficiency, and to boost its marketing and customer development capabilities for significant growth in overseas business [4]. - The company is also focusing on cultivating new production capabilities, particularly in strategic emerging industries like controllable nuclear fusion, which will provide high-quality low-temperature equipment for fusion reactor construction, including refrigeration machines, expanders, heat exchangers, low-temperature valves, and storage tanks, as well as high-purity specialty gases [4].